Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MREO Mereo Biopharma Group Plc

Post-Mkt 05-12 17:50:45 EDT

0.2460

+0.0035

+1.44%

盘后0.2504

+0.0044+1.79%

17:48 EDT

High0.2600	Low0.2378	Vol2.53M
Open0.2450	D1 Closing0.2425	Amplitude9.15%
Mkt Cap39.15M	Tradable Cap24.72M	Total Shares159.13M
T/O630.09K	T/O Rate2.52%	Tradable Shares100.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":0.246,"timestamp":1778616000000,"preClose":0.2425,"halted":0,"volume":2528357,"hourTrading":{"tag":"盘后","latestPrice":0.2504,"preClose":0.246,"latestTime":"17:48 EDT","volume":3996,"amount":1012.32178488,"timestamp":1778622506403,"change":0.0044,"changeRate":0.017886,"amplitude":0.048374},"delay":0,"changeRate":0.014432989690721662,"floatShares":100470459,"shares":159131700,"eps":-0.26286,"marketStatus":"Post-Mkt","change":0.0035,"latestTime":"05-12 17:50:45 EDT","open":0.245,"high":0.26,"low":0.2378,"amount":630094.8819984,"amplitude":0.091546,"askPrice":0.2504,"askSize":5567,"bidPrice":0.23,"bidSize":13500,"shortable":3,"etf":0,"ttmEps":-0.26286,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1778630400000},"marketStatusCode":4,"adr":0,"adrRate":5,"listingDate":1556078400000,"exchange":"NASDAQ","adjPreClose":0.2425,"preHourTrading":{"tag":"盘前","latestPrice":0.2401,"preClose":0.2425,"latestTime":"09:17 EDT","volume":36793,"amount":9247.384843920001,"timestamp":1778591828663,"change":-0.0024,"changeRate":-0.009897,"amplitude":0.094845},"postHourTrading":{"tag":"盘后","latestPrice":0.2504,"preClose":0.246,"latestTime":"17:48 EDT","volume":3996,"amount":1012.32178488,"timestamp":1778622506403,"change":0.0044,"changeRate":0.017886,"amplitude":0.048374},"volumeRatio":1.218009,"impliedVol":0.2533,"impliedVolPercentile":0.2948},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"2634436482","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634436482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634436482?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:14","pubTimestamp":1778598868,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down significantly late Tuesday morning, dropping 1.05% to 1,814.06 on the S&P Europe Select ADR Index.From continental Europe, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTLS","LU1829250122.USD","SQNS","LU0006061336.USD","LYG","LU0162691827.USD","OPRA","BK4532","BK4521","BTI","BK4546","GSK","BK4132","BK4588","BK4207","IEUR","SLN","LU2543165471.USD","CUK","BK4142","NOK","MREO","GSKH","BK4139","CRTO","IE00BMPRXR70.SGD","BK4023","BK4141","AKTX","IE00BFMHRM44.USD","BK4007","BK4585","BK4077","BK4020","AFG","LNOK","BTI.AU","LU0072461881.USD","BK4075","BK4117","TRVG","BK7062","EPV","DBVT","BK4107","CLLS","VOD","GSK.UK","IE00BMPRXN33.USD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634877210","title":"Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO), DocGo (DCGO) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634877210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634877210?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:52","pubTimestamp":1778593951,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mereo Biopharma Group Plc (MREO), DocGo (DCGO) and S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mereo-biopharma-group-plc-mreo-docgo-dcgo-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mereo-biopharma-group-plc-mreo-docgo-dcgo-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","MREO","BK4581","DCGO","BK4196","LU0128526141.USD","BK4505","HCSG","BK4585","SYRE","BK4139","BK4588","XLV","XBI","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634212731","title":"Mereo BioPharma Group PLC reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634212731","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634212731?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:32","pubTimestamp":1778592750,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group PLC reports results for the quarter ended March 31 - Earnings SummaryMereo BioPharma Group PLC MREO.OQ reported a quarterly adjusted loss of 1 cent per share for the quarter ende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P1YY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215799","title":"Mereo BioPharma Q1 Net Income USD -6.719 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215799","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215799?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:42","pubTimestamp":1778586168,"startTime":"0","endTime":"0","summary":"May 12 (Reuters) - Mereo BioPharma Q1 operating income USD -8.766 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 12-MAY-202611:26:35.343 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nRSD5vgNgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634152872","title":"UK's Mereo BioPharma Q1 net loss narrows on lower admin costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2634152872","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634152872?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:39","pubTimestamp":1778585945,"startTime":"0","endTime":"0","summary":"UK's Mereo BioPharma Q1 net loss narrows on lower admin costsOverviewUK rare disease drug developer's Q1 net loss narrowed yr/yr, driven by reduced admin expensesCompany's R&D expenses rose, mainly du","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL1N41P0KQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634151982","title":"Mereo BioPharma Group Q1 EPS $(0.01), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2634151982","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634151982?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:35","pubTimestamp":1778585754,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52481008/mereo-biopharma-group-q1-eps-0-01-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634553215","title":"Press Release: Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2634553215","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634553215?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":"LONDON, May 12, 2026  -- Mereo BioPharma Group plc  , a clinical-stage biopharmaceutical company focused on rare diseases, today announced financial results for the first quarter ended March 31, 2026, and provided an update on recent corporate developments.-- Further analyses of the data from the Orbit and Cosmic Phase 3 studies,-- While neither study achieved statistical significance against the primary. endpoints of reduction in annualized clinical fracture rate compared to. placebo  or bisphosphonates , both studies achieved high. statistical significance against the key secondary endpoint of. improvement in bone mineral density versus control as well as reductions. in vertebral fractures and improvements in patient reported outcomes.  associated with disease severity, pain / discomfort and daily. -- The safety profile of setrusumab was consistent with that observed in. -- Based on the Phase 3 data analysis from both global Phase 3 studies and. the safety profile of setrusumab, Mere","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4126","MREO","BK4505","BK4139","BK4588","OI","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634753238","title":"European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634753238","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634753238?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:05","pubTimestamp":1778511940,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company Cellectis , which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies  and telecommunications company Ericsson , which increased 4.9% and 3.2% respectively.The decliners from continental Europe were led by consumer goods company Unilever  and biopharmaceutical company Grifols , which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera  and accommodations booking site trivago , which were down 1% each.The gainers from the UK were led by cruise line operator Carnival  and pharmaceutical company Silence Therapeutics , which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therape","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK4134","LU0648005311.SGD","BDRX","AMRN","BK4020","UL","LU0124676726.USD","BK4183","BK4588","BK4505","GRFS","AUTL","BK4141","CLLS","DAVA","MREO","LU0084288595.USD","BK4554","ULVR.UK","BK4592","BK4139","BK4591","DAVA.AU","TRVG","SQNS","BK4142","EPV","ERIC","OPRA","SLN","CUK","BK4077","DBVT","LU0689626769.HKD","IEUR","BK4585","BK4023","AKTX","BK4515","AFG","BK4107","BK4007","UN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634846394","title":"Mereo BioPharma Group PLC  expected to post a loss of 1 cent a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634846394","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634846394?lang=en_us&edition=fundamental","pubTime":"2026-05-09 00:15","pubTimestamp":1778256910,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group PLC  expected to post a loss of 1cent a share - Earnings Preview Mereo BioPharma Group PLC MREO.OQ, MREO.O is expected to  show a rise in quarterly revenue when it reports  resul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L214:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633321931","title":"European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2633321931","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633321931?lang=en_us&edition=fundamental","pubTime":"2026-05-06 23:10","pubTimestamp":1778080223,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 1.98% to 1,843.18 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking company trivago  and lender ING Group , which advanced 14% and 5% respectively. They were followed by biopharmaceutical company Cellectis  and lender Banco Santander , which climbed 4.8% and 4.2% respectively.The decliners from continental Europe were led by internet advertising firm Criteo  and petroleum refiner Equinor , which shed 18% and 8.4% respectively. They were followed by semiconductor company Sequans Communications  and oil and gas company Eni , which dropped 5.8% and 4.5% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and insurance company Prudential , which rose 9.4% and 6.2% respectively. They were followed by mining company BHP Group  and lender Barclays , which were up 5.3% and 5.2% ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4141","SHEH","GUSH","CLLS","PUK","DIG","BK4107","BCS","USE","EQNR","BK4588","DRIP","LU1829250122.USD","AFG","IEO","SQNS","VDE","BPH","DRLL","LU0278409577.USD","BK4201","BHP","FTXN","BK4117","CRTO","DBC","SAN.AU","SHEL","BK4207","BP","IXC","IEUR","LU0006061336.USD","LU0162691827.USD","AKTX","E","DBE","MREO","ING.AU","PXJ","BHP.AU","ING","SAN","XES","ERX","TRVG","BK7142","BK4585","NCNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632652327","title":"European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2632652327","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632652327?lang=en_us&edition=fundamental","pubTime":"2026-04-30 23:06","pubTimestamp":1777561599,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts rose late Thursday morning, gaining 2.20% to 1,818.51 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and lender ING Groep , which advanced 5.3% and 4.9% respectively. They were followed by biopharmaceutical firm Grifols  and consumer goods firm Unilever , which rose 3.2% and 3.1% respectively.The decliners from continental Europe were led by internet advertising firm Criteo  and telecommunications company Nokia , which fell 3.2% and 1.9% respectively.The gainers from the UK were led by cruise line operator Carnival  and utilities company National Grid , which rose 4.8% and 3.5% respectively. They were followed by Lloyds Banking Group  and telecommunications operator Vodafone Group , which were up 2.6% and 2.3% respectively.The decliners from the UK and Ireland were led by software firm Endava  and Bicycle Therapeutics , which lost 5.2% and 2.3% re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ULVR.UK","IE00BMPRXN33.USD","BK4183","BK4547","LU1093756325.SGD","BK4009","NVOH","LU0154236417.USD","UL","BK4142","BK7104","BK4207","ING","BK4585","BK4208","BCYC","BK4592","IE00BFMHRM44.USD","BK4134","IE00BZ1G4Q59.USD","BK4007","LU0084288595.USD","LU0648005311.SGD","VOD","NVO","GRFS","IE00BKVL7J92.USD","BK7141","MREO","BK4532","NVOX","BK4588","BK7505","CRTO","LYG","DAVA","BK4139","BK4599","BK4132","BK4521","BK4107","BK4117","AMRN","NGG","UN","IE00BMPRXR70.SGD","LU1093756168.USD","NOK","LU0124676726.USD","CUK","BK4505","LNOK","LU0689626769.HKD","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631054666","title":"European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2631054666","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631054666?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:05","pubTimestamp":1777475127,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Wednesday morning, declining 0.45% to 1,779.46 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications firm Nokia  and medical device maker EDAP , which rose 6.1% and 3.8% respectively. They were followed by petroleum refiner Equinor  and Banco Santander , which were up 2.7% and 1% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and healthcare tech firm Royal Philips , which fell 6.1% and 5.6% respectively. They were followed by internet browser company Opera  and semiconductor company Sequans Communications , which lost 3.2% and 3.1% respectively.The gainers from the UK were led by communications company WPP  and software firm Endava , which advanced 2.7% and 1.2% respectively. They were followed by oil and gas company Shell  and educational publisher Pearson , which increased 1% and 0.7% respectively.The ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SHEH","OPRA","LU0300736062.USD","BK4547","DAVA","GSK","WPP.AU","AKTX","BK4207","BK4204","BK4532","IE00BMPRXR70.SGD","LU0278409577.USD","SAN.AU","BK4009","WPP","NOK","DAVA.AU","GSK.UK","BK4521","GSKH","SHEL","LU1162221912.USD","BK4007","LU0084288595.USD","AFG","PHG","LU1829250122.USD","BK4588","BK4082","EDAP","SAN","MREO","BK4139","CLLS","BK4107","EQNR","LU0320765646.SGD","PSO","BK4111","BK4117","LU2236285917.USD","LU0648005311.SGD","BK4020","SLN","BK7142","LNOK","BK4201","SQNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630304374","title":"Viridis lands rare earths stalwart to drive Brazilian project","url":"https://stock-news.laohu8.com/highlight/detail?id=2630304374","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630304374?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:17","pubTimestamp":1777339037,"startTime":"0","endTime":"0","summary":"Viridis Mining and Minerals has strengthened its board by appointing global rare earths veteran Geoff Bedford. The former Molycorp CEO joins as the company pushes towards a final investment decision in Brazil.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-22205161/c28ea7001b25bad7fadbbb2f12b2354cd9034427.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22205161/c28ea7001b25bad7fadbbb2f12b2354cd9034427.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/viridis-lands-rare-earths-stalwart-to-drive-brazilian-project-c-22205161","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/viridis-lands-rare-earths-stalwart-to-drive-brazilian-project-c-22205161","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4505","MREO","REMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629053914","title":"European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2629053914","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629053914?lang=en_us&edition=fundamental","pubTime":"2026-04-21 23:14","pubTimestamp":1776784468,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were falling sharply late Tuesday morning, dropping 1.15% to 1,812.72 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and internet browser company Opera , which rose 2.7% and 1.7% respectively. They were followed by 3D printer company Materialise  and medical device maker EDAP TMS , which were up 1.2% each.The decliners from continental Europe were led by biopharmaceutical company argenx  and pharmaceutical company Novo Nordisk , which fell 3% and 2.8% respectively. They were followed by biotech firm Evaxion  and pharmaceutical company Ascendis Pharma , which were down 2.7% each.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and software firm Endava , which advanced 6.4% and 2.7% respectively. They were followed by education company Pearson  and pharmaceutical company Silence Therapeutics , which increased 1.2% and 0.9% res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","CUK","IE0002141913.USD","LU0320765992.SGD","NVOH","OPRA","EDAP","IE00BJT1NW94.SGD","LU0154236417.USD","BK4505","BK4007","LU0084288595.USD","BK4588","BK4599","IE00B2B36J28.USD","LU1093756325.SGD","LU2324357040.USD","DAVA","MTLS","BK4585","BK4107","BK7104","LU0648005311.SGD","LU1093756168.USD","ARGX","BK4546","IE0034235188.USD","IE00BJJMRZ35.SGD","BK4117","IE00BZ1G4Q59.USD","NCNA","PSO","NVOX","BK4023","SLN","BK4111","BK4134","BK4204","IE00B4R5TH58.HKD","MREO","LU0889565916.HKD","ASND","BK4142","BK4532","BK4082","BK4201","LU0109394709.USD","LU1983260115.SGD","NVO","EQNR","IE00BKVL7J92.USD","AKTX","EVAX","BDRX","BK4139","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627235546","title":"European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2627235546","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627235546?lang=en_us&edition=fundamental","pubTime":"2026-04-15 23:12","pubTimestamp":1776265924,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading lower late Wednesday morning, declining 0.54% to 1,835.78 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS  and biopharmaceutical firm Grifols , which advanced 3% and 2.6%, respectively. They were followed by software company SAP  and biopharmaceutical company argenx , which increased 2.5% each.The decliners from continental Europe were led by furniture maker Natuzzi  and telecommunications company Nokia , which dropped 4.2% and 1.6%, respectively. They were followed by telecommunications company Ericsson  and petroleum refiner Equinor , which lost 1.5% and 1.2%, respectively.The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals  and software company Endava , which rose 3.2% each. They were followed by biopharmaceutical companies Amarin  and NuCana , which were up 3% and 2.3% respectively.The decliners from the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443382.USD","LU0320765992.SGD","NOK","EQNR","LU0648005311.SGD","DAVA.AU","LU1983260115.SGD","LU2237443978.SGD","NCNA","BDRX","LU0289739699.SGD","BK4554","AZN","AMRN","IE00BMPRXN33.USD","MREO","NTZ","BK4208","SAP","AFG","IE00B2B36J28.USD","BK4134","BK4591","IE0009355771.USD","BK4139","BK4201","LNOK","LU0889565916.HKD","BK4007","IE0002141913.USD","ERIC","IE00BMPRXR70.SGD","BK4082","BK4588","DAVA","EDAP","IE00B3T34201.USD","NGG","BK4023","GRFS","TRIB","LU0058720904.USD","BK4107","BK4568","BK4515","LU0084288595.USD","LU2237443622.USD","ARGX","LU2456880835.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627451298","title":"European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2627451298","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627451298?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:04","pubTimestamp":1776092679,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts began the week little changed late Monday morning, edging 0.02% higher to 1,822.16 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and telecommunications company Nokia , which advanced 26% and 9.3%, respectively. They were followed by furniture maker Natuzzi   and biotech firm Evaxion , which climbed 7.1% and 3.4%, respectively.The decliners from continental Europe were led by accommodations booking company trivago  and brewing company Anheuser-Busch InBev , which dropped 3.3% and 1.2%, respectively. They were followed by pharmaceutical company Sanofi  and lender Banco Santander , which were off 0.9% and 0.8%, respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Mereo BioPharma Group , which rose 7% and 4.8%, respectively. They were followed by biopharmaceutical companies NuCana","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNY","NOK","BK4158","BK4585","BK4142","BK7119","NCNA","BDRX","CLLS","MREO","BK4547","IE00BMPRXN33.USD","NTZ","SAN.AU","AFG","BUD","BK4207","EVAX","SLN","BK4077","BK4139","BCS","LNOK","BK4095","BK4007","IE00BMPRXR70.SGD","BK4082","BK4588","BK7142","BK4117","TRIB","TRVG","BK4505","BUD.AU","BK4107","CUK","SAN","BK4020","IE00BFXG1179.USD","BCYC","BK4521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625567741","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2625567741","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625567741?lang=en_us&edition=fundamental","pubTime":"2026-04-06 23:06","pubTimestamp":1775487989,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week lower late Monday morning, declining 0.21% to 1,753.66 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS  and biopharmaceutical company Cellectis , which rose 5% and 2.6% respectively. They were followed by telecommunications company Nokia  and 3D printer company Materialise , which were up 1.5% and 1.1% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and software firm SAP , which fell 1.7% and 1% respectively. They were followed by telecommunications company Ericsson  and semiconductor company Sequans Communications , which were off 0.4% and 0.2% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group  and software company Endava , which advanced 3.7% and 1.2% respectively. They were followed by communications company WPP  and lender Lloyds ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7511","NOK","BK4585","LU0648005311.SGD","DAVA.AU","DBVT","BDRX","AKTX","CLLS","LU0300736492.USD","BK4554","BK4547","MREO","LYG","BK4009","BK4141","SAP","AFG","BK4207","BK4134","BK4591","LU0300736062.USD","SLN","BK4139","BK4613","BK7095","LNOK","ERIC","IE00BMPRXR70.SGD","BK4082","BK4588","DAVA","EDAP","BK4023","BHP.AU","BK7507","BK4505","MTLS","SQNS","BK4528","BK4107","WPP","BK4020","BK4515","BHP","WPP.AU","BK4168","LU0084288595.USD","BK4546","BK4521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624500729","title":"European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2624500729","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624500729?lang=en_us&edition=fundamental","pubTime":"2026-04-02 23:09","pubTimestamp":1775142598,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.69% to 1,746.31 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and oil and gas company Eni , which climbed 4.5% and 4.1% respectively. They were followed by petroleum refiner Equinor  and telecommunications company Nokia , which advanced 2.8% and 2.2% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and lender Banco Santander , which dropped 6.5% and 3.5% respectively. They were followed by accommodations booking company trivago  and medical device maker EDAP TMS , which lost 2.4% each.The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals , which soared 94%, followed by biopharmaceutical company Mereo BioPharma Group , which was up 3.1%. Oil and gas companies BP  and Shell  rose 1.9% and 1.8% respectively.The decliner","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0300736062.USD","AKTX","EQNR","SAN","TRVG","BK4585","DAVA","BK4007","LU0098860793.USD","EDAP","IE00BMPRXN33.USD","LU0072461881.USD","BK4141","CUK","MREO","NOK","BK4107","LU2236285917.USD","EVAX","BK4082","BK4201","SAN.AU","BP","SHEH","SHEL","BK4117","E","BK4077","BK4139","LU0278409577.USD","AFG","LU0084288595.USD","BPH","BK4142","LNOK","LU0648005311.SGD","BK4020","LU0320765646.SGD","LU1162221912.USD","LU0300736492.USD","LU0162691827.USD","BK4588","SQNS","BK4547","BK4207","BK4134","TRIB","DAVA.AU","BDRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623953321","title":"European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2623953321","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623953321?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:22","pubTimestamp":1774970573,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 1.72% to 1,721.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Cellectis , which climbed 7.6% and 4.4% respectively. They were followed by pharmaceutical company Ascendis Pharma  and biopharmaceutical company Grifols , which advanced 3.9% and 3.6% respectively.The only decliners from continental Europe were biotech firm Evaxion  and consumer goods company Unilever , which fell 5.8% and 5.5% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and pharmaceutical company Silence Therapeutics , which rose 10% and 6% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group  and Bicycle Therapeutics , which were up 5.3% and 4.8% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech  and bioph","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0689626769.HKD","LU0320765992.SGD","LU0124676726.USD","TRIB","BK4505","BK4007","BK4588","AUTL","BK4585","BK4107","ULVR.UK","CLLS","BCYC","UN","BK4117","SLN","BK4183","UL","SNN","DBVT","MREO","LU0889565916.HKD","GRFS","ASND","LU0109394709.USD","BK4082","AKTX","BK4592","EVAX","BDRX","BK4139","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623341038","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2623341038","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623341038?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:07","pubTimestamp":1774883261,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary kicked off the week higher late Monday morning, rising 0.78% to 1,700.55 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and internet advertising firm Criteo , which rose 3.8% and 3.4%, respectively. They were followed by software firm SAP  and pharmaceutical company Novo Nordisk , which were up 1.4% each.The decliners from continental Europe were led by medical device maker EDAP TMS  and biopharmaceutical company Cellectis , which dropped 2.8% and 2.5%, respectively. They were followed by accommodations booking company trivago  and biotech firm BioNTech , which lost 1.8% and 0.4%, respectively.The gainers from the UK were led by pharmaceutical company AstraZeneca , which advanced by 2.9%. It was followed by pharmaceutical company Silence Therapeutics  and utilities company National Grid , which increased 2.4% and 2.3%, respectively.The decliners from the UK and Irel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","NVOH","WPP","BK4023","NVOX","LU0109394709.USD","BK4107","IE00BKVL7J92.USD","IE00BFMHRM44.USD","AZN","CLLS","SAP","NGG","BK4201","BK4208","BK4139","LU0154236417.USD","NVO.AU","LU2456880835.USD","BK4548","LU2462157665.USD","CRTO","WPP.AU","BK4528","AFG","BK4599","SLN","BK4009","IE00B3T34201.USD","BK4613","EDAP","BK4077","IE00BZ1G4Q59.USD","BK4551","BK4588","BK4117","EQNR","IHG","TRVG","BK4585","AMRN","MREO","LU2417539215.USD","LU0058720904.USD","BK4505","BNTX","LU0320765992.SGD","BK4007","BK7104"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1553},{"period":"1month","weight":-0.2629},{"period":"3month","weight":-0.4085},{"period":"6month","weight":-0.8682},{"period":"1year","weight":-0.8994},{"period":"ytd","weight":-0.418}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.0881},{"period":"3month","weight":0.0682},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.31},{"period":"ytd","weight":0.0841}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.015037},{"month":2,"riseRate":0.428571,"avgChangeRate":0.010455},{"month":3,"riseRate":0,"avgChangeRate":-0.168155},{"month":4,"riseRate":0.571429,"avgChangeRate":0.09425},{"month":5,"riseRate":0.125,"avgChangeRate":-0.117736},{"month":6,"riseRate":0.714286,"avgChangeRate":0.399821},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.055261},{"month":8,"riseRate":0.857143,"avgChangeRate":0.105012},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100596},{"month":10,"riseRate":0.428571,"avgChangeRate":0.068788},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.101401},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001557}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc","securityTypeName":"DR","adrRate":"1:5"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}